SOLVAY 1220 (Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease)

Generic Name: pancrelipase

Pill imprint SOLVAY 1220 has been identified as Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease.

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 66,400 units amylase; 20,000 units lipase; 75,000 units protease is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for SOLVAY 1220

Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease SOLVAY 1220
Creon 20
Generic Name:
pancrelipase
Imprint:
SOLVAY
1220
Strength:
66,400 units amylase; 20,000 units lipase; 75,000 units protease
Color:
Orange / Clear
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Solvay Pharmaceuticals Inc.
National Drug Code (NDC):
00032-1220
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-3475 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)